112 related articles for article (PubMed ID: 30270520)
1. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.
Wang L; Li W; Li K; Guo Y; Liu D; Yao Z; Lin X; Li S; Jiang Z; Liu Q; Jiang Y; Zhang B; Chen L; Zhou F; Ren H; Lin D; Zhang D; Yeung SJ; Zhang H
Cancer Med; 2018 Oct; 7(10):5205-5216. PubMed ID: 30270520
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
[TBL] [Abstract][Full Text] [Related]
3. Widely targeted metabolomic analyses unveil the metabolic variations after stable knock-down of NME4 in esophageal squamous cell carcinoma cells.
Zheng S; Liu T; Liu Q; Yang L; Zhang Q; Han X; Shen T; Zhang X; Lu X
Mol Cell Biochem; 2020 Aug; 471(1-2):81-89. PubMed ID: 32504364
[TBL] [Abstract][Full Text] [Related]
4. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of a low-frequency V1937I variant in FASN associated with susceptibility to esophageal squamous cell carcinoma.
Wang X; Tian J; Zhao Q; Yang N; Ying P; Peng X; Zou D; Zhu Y; Zhong R; Gao Y; Chang J; Miao X
Arch Toxicol; 2020 Jun; 94(6):2039-2046. PubMed ID: 32388819
[TBL] [Abstract][Full Text] [Related]
7. Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway.
Bednarz-Misa I; Fortuna P; Fleszar MG; Lewandowski Ł; Diakowska D; Rosińczuk J; Krzystek-Korpacka M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872669
[TBL] [Abstract][Full Text] [Related]
8. The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis.
Wang J; Luo FF; Huang TJ; Mei Y; Peng LX; Qian CN; Huang BJ
Aging (Albany NY); 2021 Sep; 13(17):21758-21777. PubMed ID: 34520390
[TBL] [Abstract][Full Text] [Related]
9. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma.
Cheng J; Liu Q; Jin H; Zeng D; Liao Y; Zhao Y; Gao X; Zheng G
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165966. PubMed ID: 32931889
[TBL] [Abstract][Full Text] [Related]
10. iTRAQ and two-dimensional-LC-MS/MS reveal NAA10 is a potential biomarker in esophageal squamous cell carcinoma.
Wang D; Chen J; Han J; Wang K; Fang W; Jin J; Xue S
Proteomics Clin Appl; 2022 May; 16(3):e2100081. PubMed ID: 35182098
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
[TBL] [Abstract][Full Text] [Related]
12. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Bellon E; Grupp K; Ghadban T; Tachezy M; Bachmann K; Izbicki JR; Simon R; Sauter G; Hube-Magg C; Melling N
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2879-2884. PubMed ID: 34148155
[TBL] [Abstract][Full Text] [Related]
13. PD_BiBIM: Biclustering-based biomarker identification in ESCC microarray data.
Patowary P; Bhattacharyya DK
J Biosci; 2021; 46():. PubMed ID: 34148879
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.
Mai Z; Yuan J; Yang H; Fang S; Xie X; Wang X; Xie J; Wen J; Fu J
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35993362
[TBL] [Abstract][Full Text] [Related]
15. MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas.
Wang Z; Yang H; Zhang R; Luo B; Xu B; Zhu Z; Lin P
Autoimmunity; 2021 Sep; 54(6):373-383. PubMed ID: 34160343
[TBL] [Abstract][Full Text] [Related]
16. A pathway-based computational framework for identification of a new modal of multi-omics biomarkers and its application in esophageal cancer.
Zhou Q; Ye W; Yu X; Bao YJ
Comput Methods Programs Biomed; 2024 Apr; 247():108077. PubMed ID: 38382307
[TBL] [Abstract][Full Text] [Related]
17. Androgen Receptor/AP-1 Activates
Cai J; Huang F; Gao W; Gong T; Chen H; Liu Z
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136265
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of FAM134B in ER-phagy and diseases.
Mo J; Chen J; Zhang B
Cell Death Dis; 2020 Nov; 11(11):983. PubMed ID: 33199694
[TBL] [Abstract][Full Text] [Related]
19. Active Estrogen-Succinate Metabolism Promotes Heme Accumulation and Increases the Proliferative and Invasive Potential of Endometrial Cancer Cells.
Lu JJ; Zhang X; Abudukeyoumu A; Lai ZZ; Hou DY; Wu JN; Tao X; Li MQ; Zhu XY; Xie F
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509133
[TBL] [Abstract][Full Text] [Related]
20. The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis.
Chen Q; Guo P; Hong Y; Mo P; Yu C
Cell Biosci; 2024 Mar; 14(1):41. PubMed ID: 38553750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
